Phonak Audéo Lumity vs Resound Vivia 9 60S microRIE

The Phonak Audéo Lumity is a premium prescription behind-the-ear hearing aid released in 2022, priced at $4,398. In HearAdvisor's lab testing, it earned a SoundScore of 4.1/5 (A grade), ranking #21 of 36 prescription hearing aids tested. This device demonstrates clear strengths in specific performance areas. Music streaming quality is strong at 4.1/5, scoring 1.46 points above the category average—a notable advantage for users who frequently stream audio from their phones. Feedback handling is excellent at 5.0/5, meaning the Lumity maintained stability without audible feedback during our standardized challenge tests. Speech in quiet environments also performs solidly at 3.7/5, measuring 0.37 points above the prescription category average. However, the Lumity shows a significant weakness in own-voice comfort, scoring just 1.0/5—a full 1.75 points below the category average. This low score suggests users may notice more occlusion or an unnatural quality to their own voice. Speech in noise performance is mixed at 2.1/5; while this is slightly above the category average (+0.19 points), it remains modest in absolute terms. The Audéo Lumity is best suited for users who prioritize excellent streaming quality and reliable feedback control, and who are less sensitive to own-voice occlusion effects. Those who struggle primarily with speech understanding in noisy environments may want to compare against higher-scoring competitors in this price range, such as the Phonak Sphere Infinio or Oticon Intent.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.